BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 17, 2017
View Archived Issues
Galderma initiates phase II trial of NP-000888 for plaque and nail psoriasis
Read More
Signum Biosciences awarded NIAID grant to develop candidate for atopic dermatitis
Read More
The University of Nantes presents new antifungal/antiparasitic agents.
Read More
Catalyst Therapeutics identifies new bromodomain inhibitors
Read More
Phase II trial investigates gene therapy CYL-02 for locally advanced pancreatic cancer
Read More
U.S. orphan designations granted to atezolizumab, atezolizumab plus cobimetinib for melanoma
Read More
G100 given FDA orphan drug designation for follicular lymphoma
Read More
Versant Ventures announces launch of Jecure Therapeutics
Read More
Spotlight Innovation enters second Zika agreement with Florida State University
Read More
FDA approves Spiriva Respimat for use in children
Read More
NIH Blueprint Neurotherapeutics Network awards grant to Knopp Biosciences
Read More
Tracon Pharmaceuticals begins dosing in phase III TAPPAS study of TRC-105
Read More
Amygdala Neurosciences acquires ALDH2 inhibitor from Gilead
Read More
Capricor terminates natriuretic peptide receptor agonist license agreement with Mayo Clinic
Read More
High virologic response rates seen with bictegravir regimen in phase II trial
Read More
Phase III study of Lynparza meets primary endpoint in BRCA-mutated metastatic breast cancer
Read More
Five-marker methylation panel detected for ulcerative colitis-associated neoplasia
Read More
XBiotech's phase II study of MABp1 meets primary endpoint
Read More
Chugai seeks Japanese approval for atezolizumab for NSCLC
Read More
FDA accepts Mylan and Biocon's BLA for MYL-1401H for review
Read More
Clinical results with velmanase alfa in adults and children reported
Read More
Astellas Pharma describes novel MC4 receptor agonists
Read More
Allergan discloses new fMet-Leu-Phe/N-formyl peptide receptor 2 agonists
Read More
Phase I/II results of rAAV2/5-hNA-GLU in children with MPS IIIB presented
Read More